Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1181 of 5804
-
Immunotherapy-Chemo cocktail shows promise for Hard-to-Treat bile duct cancer
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate the safety and effectiveness of a new combination therapy for patients with biliary tract cancer that cannot be removed by surgery. Participants will receive an immunotherapy drug called adebrelimab combined with two chemotherapy …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Bile duct cancer surgery showdown: total removal may lower recurrence risk
Disease control Recruiting nowWhen lymph node dissection of stations 12 and 13 is performed, resecting the bile duct from the superior portion of the pancreas to the confluence of the right and left hepatic ducts allows complete removal of the station 12 and 13 lymph nodes. Preserving the bile duct from the s…
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New pill targets tough cancers with genetic flaw
Disease control Recruiting nowSolid tumours are abnormal lumps of tissue that can occur in different parts of the body. The tumours involved in this study have specific genetic characteristics that can make them more aggressive and challenging to treat. The study will test whether GSK5460025 alone or in combi…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowAn open-label, multicenter, phase II clinical study to evaluate the efficacy and safety of LBL-024 in combination with other drugs for the treatment of patients with advanced solid tumour.
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Smart contact lenses could revolutionize glaucoma monitoring
Diagnosis ENROLLING_BY_INVITATIONThis study is exploring the effectiveness and safety of soft contact lenses with embedded sensors, called smart contact lenses. Smart contact lenses are used to measure the pressure inside the eye.
Phase: NA • Sponsor: Indiana University • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
AI coaches new moms on pelvic floor exercises in remote rehab trial
Disease control CompletedPelvic Floor Rehabilitation Training Prescription Label: An individualized training prescription generated by aggregating a comprehensive profile of maternal information through AI and applying data deep-mining algorithms, aiming to deliver targeted and precise interventions for …
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a smartphone app and two sensors prevent tension headaches?
Disease control Recruiting nowThe purpose of this study is to test a therapist-independent home-based smartphone app-based biofeedback treatment in adults with tension type headache. The aim of the study is to assess the safety and performance of the Cerebri-TTH biofeedback device as a preventive treatment in…
Phase: NA • Sponsor: Helse Nord-Trøndelag HF • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New pill HRS-7085 aims to tame ulcerative colitis
Disease control Recruiting nowThis study is a randomized, double-blind, placebo-controlled Phase II clinical trial comprising screening period, treatment period, and follow-up period. This phase 2 study is being conducted to evaluate the efficacy, safety and pharmacokinetics of HRS-7085 in patients with moder…
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Knee break breakthrough? study tests best surgery for seniors
Disease control Recruiting nowPeriprosthetic distal femur fractures are a significant source of morbidity and mortality for elderly patients. One treatment option involved a surgical fixation with plates or nails, screws and cables/wires along the side of your fractured bone. The second method consists in rep…
Phase: NA • Sponsor: Unity Health Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Broccoli power: could cruciferous veggies stop bladder cancer return?
Disease control OngoingEmerging evidence highlights the importance of nutrition in modulating cancer-related pathways, suggesting that specific dietary patterns and food choices may influence cancer risk. A protective role has been suggested for high consumption of vegetables, non-saturated fat oil (Me…
Phase: NA • Sponsor: S. Andrea Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Knee replacement showdown: surgery vs. intensive medical care
Disease control Recruiting nowKnee is the most common site of osteoarthritis. Treatment of knee osteoarthritis starts with a full course of medical therapy, followed by surgery to replace the knee with a prosthesis if this strategy fails, or in advanced cases. However, the new recommendations of the French rh…
Phase: NA • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for rare blood cancer: zanubrutinib trial targets untreated patients
Disease control Recruiting nowThe purpose of this study is to measure the efficacy and safety with zanubrutinib in adults with Treatment-Naive (TN) Waldenström Macroglobulinemia (WM). The main objective of this Phase 4 study is to further characterize the efficacy of zanubrutinib in Chinese participants with …
Phase: PHASE4 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Mind-Controlled apple vision pro could help paralyzed people speak
Symptom relief Not yet recruitingThe goal of this study is refine the usability of a BCI capable communication platform. The study will take place in the United States area and will enroll up to 10 participants with late stage ALS, traumatic brain injury (TBI) or spinal cord injury (SCI) that have assistive com…
Phase: NA • Sponsor: Cognixion • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New pill targets Hard-to-Treat cancers with RAS mutations
Disease control Recruiting nowThis is an open-label, multi-center phase I clinical study to evaluate the safety, tolerability, and pharmacokinetics of HRS-2329 in participants with advanced solid tumors harboring RAS mutations or amplifications.
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New device aims to unclog the Heart's drain for stubborn heart failure patients
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to evaluate the efficacy of CS Reducer implantation in patients with HFpEF and CMD on left ventricular filling pressures, specifically invasive measurement of PAWP during standardized exercise.
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a common pill protect new Moms' hearts after complicated pregnancies?
Disease control Recruiting nowThe hypertensive disorders of pregnancy (preeclampsia and gestational hypertension) are associated with increased long-term maternal risk of developing cardiovascular disease. Recent evidence suggests that activation of the mineralocorticoid receptor promotes ongoing susceptibili…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New daily adaptive radiotherapy aims to spare saliva glands in head and neck cancer patients
Symptom relief Recruiting nowThis is a randomized, single centre, single blinded prospective study comparing the standard of care imaging guided radiation therapy and daily adaptive radiotherapy (ART) for submandibular gland-sparing in head and neck cancer
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Can a cancer drug tame rare bleeding Disorder's heart complications?
Disease control ENROLLING_BY_INVITATIONHigh cardiac output secondary to hepatic arteriovenous malformations may be isolated or associated with left heart failure with post-capillary pulmonary hypertension. More rarely, precapillary pulmonary hypertension develops, linked to obstructive pulmonary arterial remodeling, r…
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Fasting two days a week could shrink fatty liver, new study hopes to prove
Disease control Recruiting nowThe recommended treatment for metabolic dysfunction-associated steatotic liver disease (MASLD) currently focuses on lifestyle changes, including dietary adjustments and increased physical activity. Intermittent fasting is a specific dietary approach in which food intake is restri…
Phase: NA • Sponsor: Universität des Saarlandes • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New study tests if keyhole spine surgery can beat traditional scoliosis operation
Disease control Not yet recruitingSurgical treatment for idiopathic scoliosis usually involves open surgery from the back (posterior approach). This method corrects the curve and stabilizes the spine using screws and rods, followed by a fusion of the treated segments. The goal is to achieve the best possible alig…
Phase: NA • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC